Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L0ZP
|
|||
Former ID |
DNC006469
|
|||
Drug Name |
3-methoxy-4-(oxazol-5-yl)aniline
|
|||
Synonyms |
3-methoxy-4-(oxazol-5-yl)aniline; 198821-79-3; 3-METHOXY-4-(1,3-OXAZOL-5-YL)ANILINE; Benzenamine, 3-methoxy-4-(5-oxazolyl)-; 3-methoxy-4-(5-oxazolyl)aniline; CHEMBL45870; 5-(4-amino-2-methoxyphenyl)oxazole; AK116113; A1-00139; SCHEMBL1353846; CTK4E2632; KS-00000NNJ; DTXSID80572997; MolPort-006-666-066; KYCMMXMEXWSPCV-UHFFFAOYSA-N; ZINC2518269; FCH848314; 3-methoxy-4-(oxazol-5-yl) aniline; BDBM50127715; 3-Methoxy-4-oxazol-5-yl-phenylamine; AKOS006278384; CS-W005501; MP-1879; DS-2798; 3-methoxy-4-(oxazol-5-yl)benzenamine; AJ-37081
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C10H10N2O2
|
|||
Canonical SMILES |
COC1=C(C=CC(=C1)N)C2=CN=CO2
|
|||
InChI |
1S/C10H10N2O2/c1-13-9-4-7(11)2-3-8(9)10-5-12-6-14-10/h2-6H,11H2,1H3
|
|||
InChIKey |
KYCMMXMEXWSPCV-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 198821-79-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) | Target Info | Inhibitor | [1] |
BioCyc | Purine nucleotides degradation | |||
Urate biosynthesis/inosine 5'-phosphate degradation | ||||
Guanosine nucleotides de novo biosynthesis | ||||
Superpathway of purine nucleotide salvage | ||||
Purine nucleotides de novo biosynthesis | ||||
Guanosine ribonucleotides de novo biosynthesis | ||||
KEGG Pathway | Purine metabolism | |||
Drug metabolism - other enzymes | ||||
Metabolic pathways | ||||
Panther Pathway | De novo purine biosynthesis | |||
Reactome | Purine ribonucleoside monophosphate biosynthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Low molecular weight indole fragments as IMPDH inhibitors. Bioorg Med Chem Lett. 2006 May 1;16(9):2535-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.